Cost-utility analysis of treating severe peripheral arterial occlusive disease

International Journal of Angiology

Volumn 15, Issue 1, 2006, Pages 25-33

  Holler, Dirk ^a   Claes, Christa ^b   Von Der Schulenburg, J Matthias Graf ^b  

^a University of Hannover ^*

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ARTERY DISEASE; ARTICLE; BYPASS SURGERY; COST OF ILLNESS; COST UTILITY ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG INFUSION; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; STATISTICAL MODEL; TREATMENT INDICATION;

EID: 33749836944     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00547-006-2073-y     Document Type: Article

References (40)

1. Altstaedt HO, Berzewski B, Breddin HK, Brockhaus W Bruhn HD, Cachovan M, Diehm C, Dorrler J, Franke CS, Gross JD (1993) Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 49:573-578.
2. Arzneimittelkommissionen der deutschen Aerzteschaft (2004) Therapieempfehlungen der Arzneimittelkommissionen der deutschen Aerzteschaft. Berlin.
3. Bertele V, Roncaglioni MC, Pangrazzi J, et al. (1998) Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Eur J Vasc Endovasc Surg 18:401-410.
4. Bliss B (1991) Treatment of limb threatening ischaemia with intravenous itoprost: a randomised double-blind placebo controlled study. UK Severe Limb Ischaemia Study Group. Eur J Vasc Surg 5:511-516.
5. Boehme H, Bruelisauer M, Haertel U, et al. (1998) Kontrollierte Zwei-Zentren-Studie zur Wirksamkeit von intraarteriellen Prostaglandin El - Infusionen bei peripherer arterieller Verschlusskrankheit im Stadium III und IV In: Heidrich H, Boehme H, Rogatti W (eds). Prostaglandin El - Wirkungen und therapeutische Wirksamkeit Berlin, Heidelberg New York: Springer, pp 118-124.
6. Bosch JL, Tetteroo E, Mali WP, Hunink MG (1998) Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 208:641-648.
7. Cutler BS, Thompson JE, Kleinsasser LJ, Hempel GK (1976) Autologus saphenous vein femoropopliteal bypass: analysis of 298 cases. Surgery 79:325-331.
8. Dawson I, Keller BP, Brand R, Pesch-Batenburg J, van Hajo BJ (1995) Late outcomes of limb loss after failed infrainguinal bypass. J Vasc Surg 21:613-622.
9. Deutsche Gesellschaft fuer Angiologie, Deutsche Gesellschaft fuer Gefaessmedizin (2001) Leitlinien zur Diagnostik und Therapie der arteriellen Verschlusskrankheit der Becken/Beinarterien. Vasa 30:1-19.
10. Faglia E, Favales F, Quarantiello A, Calia P, Brambilla G, Rampoldi A, Morabito A (1996) Feasibility and effectiveness of peripheral percutaneous transluminal balloon angioplasty in diabetic subjects with foot ulcers. Diabetes Care 19:1261-1264.
11. Faglia E, Mantero M, Caminiti M, Caravaggi C, De GR, Pritelli C, Clerici G, Fratino P, De CP, Dalla PL, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (2002) Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 252:225-232.
12. Gutteridge W, Torrie EP, Galland RB (1997) Cumulative risk of bypass, amputation or death following percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 14:134-139.
13. Hamdan AD, Rayan SS, Hook SC, et al. (2002) Bypasses to tibial vessels using polytetrafluorowethylene as the solo conduit in a predominantly diabetic population. Eur J Vasc Endovasc Surg 36:59-63.
14. Hannoveraner Konsensgruppe (2000) Deutsche Empfehlungen zur gesundheitsoekonomischen Evaluation. Revidierte Fassung des Hannoveraner Konsens. Med Klin 95:52-55.
15. Heidrich H, Ranft J, Peters A, et al. (1998) Intravenoese Prastavasin-Therapie bei peripher-arteriellen Durchblutungsstoerungen im Fontaine-Stadium III und IV. Frueh-und Spaetergebnisse einer Screening-Studie In: Heidrich H, Boehme H, Rogatti W (eds). Prostaglandin El - Wirkungen und therapeutische Wirksamkeit. Berlin Heidelberg New York: Springer, pp 112-117.
16. Holdsworth J (1997) District hospital management and outcome of critical lower limb ischaemia: comparison with national figures. Eur J Vasc Endovasc Surg 13:159-163.
17. Holler D, Claes C, von der Schulenburg JM (2004) Treatment costs and quality of life of patients with peripheral arterial occlusive disease - the German perspective. Vasa 33:145-153.
18. Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten T, Stenberg B, Tylen U, Zachrisson BF, Lindberg H (1991) Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 5:517-522.
19. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de VJ, Harrington DP (1995) Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 274:165-171.
20. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP (1994) Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 14:71-81.
21. Jamsen T, Manninen H, Tulla H, Matsi P (2002) The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vasc Interv Radiol 13:455-463.
22. Laurila J, Brommels M, Standertskjold-Nordenstam CG, Leinonen S, Lepantalo M, Edgren J, Suramo I (2000) Cost-effectiveness of percutaneous transluminal angioplasty (PTA) versus vascular surgery in limb-threatening ischaemia. Int J Angiol 9:214-219.
23. Lepantalo M, Matzke S (1996) Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 11:153-157.
24. Luther M (1997) Treatment of chronic critical leg ischaemia-a cost benefit analysis. Ann Chir Gynaecol SuppI 213:1-142.
25. Matsi PJ, Manninen HI, Suhonen MT, Pirinen AE, Soimakallio S (1993) Chronic critical lower-limb ischemia: prospective trial of angioplasty with 1-36 months follow-up. Radiology 188:381-387.
26. Norgren L, Alwmark A, Angqvist KA, Hedberg B, Bergqvist D, Takolander R, Claes G, Lundell A, Holm J, Jivegard L (1990) A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc Surg 4:463-467.
27. Scheffler P, Altmann E, Camci M, et al. (1999) Multizentrische Erhebung zur Wirksamkeit und Vertraeglichkeit wiederholter Prostavasin-Behandlungen bei Patienten mit AVK Stadium III/IV. Vasa Suppl 54:30-36.
28. Sculpher M, Michaels J, McKenna M, Minor J (1996) A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions. Int J Technol Assess Health Care 12:104-125.
29. Siebert U, Mühlberger N, Schöffski O (2000) Desk Research In: Schöffski O, Schulenburg JM (eds). Gesundheitsdkonomische Evaluation Berlin Heidelberg New York: Springer, pp 79-122.
30. Singh S, Evans L, Datta D, Gaines P, Beard JD (1996) The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg 12:359-362.
31. Soder HK, Manninen HI, Jaakkola P, Matsi PJ, Rasanen HT, Kaukanen E, Loponen P, Soimakallio S (2000) Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 11:1021-1031.
32. Stanley B, Teague B, Raptis S, Taylor DJ, Berce M (1996) Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. J Vasc Surg 23:679-685.
33. Statistisches Bundesamt. Abgekuerzte Sterbetafel 1999/2001. http://www.destatis.de.
34. Taylor LM Jr, Harare D, Dalman RL, Porter JM (1991) Limb salvage vs amputation for critical ischemia. The role of vascular surgery. Arch Surg 126:1251-1257.
35. Tefera G, Turnipseed W, Tanke T (2003) Limb salvage angioplasty in poor surgical candidates. Vasc Endovasc Surg 37:99-104.
36. Tepohl G, Lange S, Trampisch HJ, et al. (2003) Alarmierende Ergebnisse der getABI-Studie - Jeder fünfte ältere Patient in der Praxis leide an pAVK. Cardiovasc Iular 3:16-20.
37. TransAtlantic Inter-Society Consensus (TASC) (2000) Management of peripheral arterial disease (PAD). Eur J Vasc Endovasc Surg 19(suppl A):Si-250.
38. Varty K, Bolia A, Naylor AR, Bell PR, London NJ (1995) Infrapopliteal percutaneous transluminal angioplasty: a safe and successful procedure. Eur J Vasc Endovasc Surg 9:341-345.
39. Watson HR, Schroeder TV, Simms MH, Buth J, Horrocks M, Norgren L, Bergqvist D (1999) Relationship of femorodistal bypass patency to clinical outcome. Iloprost Bypass International Study Group. Eur J Vasc Endovasc Surg 17:77-83.
40. Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD, Papanicolaou G (1996) Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg 24:513-521.